JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218524

Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free

Be the first to review this product! Submit a review

|

(16 Publications)

Rabbit Recombinant Monoclonal NANOG antibody. Carrier free. Suitable for ChIP-seq, IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 16 publications.

View Alternative Names

Homeobox protein NANOG, Homeobox transcription factor Nanog, hNanog, NANOG

12 Images
Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunocytochemistry/Immunofluorescence analysis of embryonic carcinoma cells labelling Nanog with unpurified ab109250 at 1/100.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human embryonal carcinoma tissue labelling Nanog with unpurified ab109250 at 1/100.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human dysgerminoma tissue labelling Nanog with unpurified ab109250 at 1/100.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • ICC/IF

AbReview32299****

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunocytochemistry/Immunofluorescence analysis of Human Liver cells labelling Nanog with unpurified ab109250. Cells were fixed with Paraformaldehyde, permeabilized with Triton X-100 0.1% and blocked with 1% BSA for 12 hours at 4°C. Sample was incubated with primary antibody (1/500 in PBS) for 16 hour at 4°C. An Alexa Fluor®647-conjugated Donkey anti-rabbit(1/1000) IgG polyclonal was used as the secondary antibody.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

This image is courtesy of an anonymous Abreview

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human adult kidney tissue shows negative staining of Nanog with unpurified ab109250.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunocytochemistry/Immunofluorescence analysis of NCCIT(human pluripotent embryonal carcinoma) cells labelling Nanog with purified ab109250 at 1/250. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/1000) were also used.

Control 1 : primary antibody (1/100) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).

Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Flow Cytometry (Intracellular) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Intracellular Flow Cytometry analysis of NCCIT cells labelling Nanog with purified ab109250 at 1/70 (red). Cells were fixed with 4% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human seminoma tissue labelling Nanog with unpurified ab109250 at 1/100.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human seminoma tissue labelling Nanog with purified ab109250 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a goat anti-rabbit IgG H&L (HRP) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human normal colon tissue shows negative staining of Nanog with unpurified ab109250.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Immunoprecipitation - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • IP

Unknown

Immunoprecipitation - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

ab109250 (purified) at 1/40 dilution (1.5 μg/ml) immunoprecipitating Nanog in NCCIT whole cell lysate.

Lane 1 (input) : NCCIT(Human pluripotent embryonic carcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab109250 & NCCIT whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab109250 in NCCIT whole cell lysate

For western blotting, ab109250 at 1/500 dilution (1.5 μg/ml) VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/1000 dilution.

Blocking and diluting buffer : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-Nanog antibody [EPR2027(2)] (<a href='/en-us/products/primary-antibodies/nanog-antibody-epr20272-ab109250'>ab109250</a>)

Predicted band size: 34 kDa

false

ChIP-sequencing - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)
  • ChIP-seq

Supplier Data

ChIP-sequencing - Anti-Nanog antibody [EPR2027(2)] - BSA and Azide free (AB218524)

Chromatin was prepared from NCCIT (Human pluripotent embryonic carcinoma cell line) cells. ChIP was performed with 10^7 NCCIT cells and 8 µg of ab109250 [[EPR2027(2)]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab109250).

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR2027(2)

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB, IP, ICC/IF, Flow Cyt (Intra), ChIP-seq, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

100% identities with NANOGP8

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChIPseq" : {"fullname" : "ChIP-sequencing", "shortname":"ChIP-seq"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChIPseq-species-checked": "testedAndGuaranteed", "ChIPseq-species-dilution-info": "", "ChIPseq-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-low-endotoxin-azide-free-ab199376'>ab199376</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>Antigen retrieval is recommended.</p>" } } }

Product details

ab218524 is the carrier-free version of ab109250.

Species reactivity
Mouse: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Nanog also known as Nanog homeobox is a transcription factor playing an important role in maintaining the pluripotency of embryonic stem cells. The molecular weight of Nanog is approximately 35 kDa. It is found mainly in the inner cell mass of the blastocyst but it also expresses in embryonic stem cells and some adult stem cell populations. Nanog acts by binding to DNA in a sequence-specific manner to regulate gene expression essential for stem cell self-renewal and pluripotency.
Biological function summary

Nanog plays a central role in stem cell biology operating as part of a complex regulatory network. Nanog interacts with other important transcription factors like Oct4 and Sox2 forming a core pluripotency network. This network suppresses the differentiation of stem cells by regulating the expression of genes involved in cell fate decisions. By modulating the expression of different pathways Nanog ensures the maintenance of an undifferentiated state in stem cells.

Pathways

Nanog is deeply embedded in the Wnt/β-Catenin and TGF-β signaling pathways important for stem cell maintenance and differentiation. In the Wnt/β-Catenin pathway Nanog works alongside proteins like β-catenin to drive the expression of genes that promote self-renewal. Meanwhile in the TGF-β pathway Nanog acts with proteins such as Smad2/3 to balance pluripotency and differentiation signals. These pathways critically support the complex network that sustains stem cell identity and function.

Nanog's expression relates closely to its role in various cancers such as glioblastoma and colorectal cancer. Abnormally high levels of Nanog contribute to the tumorigenicity of cancer cells by maintaining their self-renewal and undifferentiated state similar to its role in stem cells. Nanog interacts with proteins like p53 known for its tumor suppressor functions often leading to challenges in cancer treatment. Understanding Nanog's influence in these pathways provides valuable insights into therapeutic targets for combating cancer stem cell resilience.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal. Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. Acts as a transcriptional activator or repressor. Binds optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-[CG][GA][CG]C[GC]ATTAN[GC]-3'. Binds to the POU5F1/OCT4 promoter (PubMed : 25825768). Able to autorepress its expression in differentiating (ES) cells : binds to its own promoter following interaction with ZNF281/ZFP281, leading to recruitment of the NuRD complex and subsequent repression of expression. When overexpressed, promotes cells to enter into S phase and proliferation.
See full target information NANOG

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

Journal of gastrointestinal oncology 13:2989-3008 PubMed36636075

2023

PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6.

Applications

Unspecified application

Species

Unspecified reactive species

Longzhu Zhong,Wanlin Tan,Qianqiong Yang,Zhaowei Zou,Rui Zhou,Yongsheng Huang,Zhenghua Qiu,Kehong Zheng,Zonghai Huang

Oncology reports 44:1627-1637 PubMed32945512

2020

MicroRNA‑137 exerts protective effects on hypoxia‑induced cell injury by inhibiting autophagy/mitophagy and maintaining mitochondrial function in breast cancer stem‑like cells.

Applications

Unspecified application

Species

Unspecified reactive species

Qiongying Hu,Yun Yuan,Yeke Wu,Yongliang Huang,Ziyi Zhao,Chong Xiao

Cell death & disease 11:542 PubMed32681092

2020

CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Zhang,Xiaoqiao Dong,Bo Yan,Wenhua Yu,Letian Shan

Cell death & disease 11:358 PubMed32398664

2020

CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions.

Applications

Unspecified application

Species

Unspecified reactive species

Yangke He,Hui Huang,Li Jin,Fang Zhang,Ming Zeng,Liang Wei,Shijia Tang,Dongqin Chen,Wansheng Wang

Journal of cellular biochemistry 121:3286-3297 PubMed31960989

2020

Exosomes from CD133 cells carrying circ-ABCC1 mediate cell stemness and metastasis in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Hong Zhao,Shixia Chen,Qiang Fu

Acta biomaterialia 102:220-230 PubMed31634626

2019

Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Jinkyu Park,Christopher W Anderson,Lorenzo R Sewanan,Mehmet H Kural,Yan Huang,Jiesi Luo,Liqiong Gui,Muhammad Riaz,Colleen A Lopez,Ronald Ng,Subhash K Das,Juan Wang,Laura Niklason,Stuart G Campbell,Yibing Qyang

IUBMB life 72:285-295 PubMed31580537

2019

Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.

Applications

Unspecified application

Species

Unspecified reactive species

Lijian Chen,Meiyun Wu,Chunyi Ji,Miaoxian Yuan,Chaoyang Liu,Qiang Yin

International journal of oncology 55:845-859 PubMed31485592

2019

Hypoxia‑induced internalization of connexin 26 and connexin 43 in pulmonary epithelial cells is involved in the occurrence of non‑small cell lung cancer via the P53/MDM2 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Shang-Gan Zeng,Xiang Lin,Ji-Chun Liu,Jin Zhou

Journal of cellular physiology 235:1051-1064 PubMed31276200

2019

MFN2 silencing promotes neural differentiation of embryonic stem cells via the Akt signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Siqi Yi,Chenghao Cui,Xiaotian Huang,Xiaohui Yin,Yang Li,Jinhua Wen,Qingxian Luan

Proceedings of the National Academy of Sciences of 112:E2337-46 PubMed25870291

2015

Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Yang,Katsuyuki Adachi,Megan A Sheridan,Andrei P Alexenko,Danny J Schust,Laura C Schulz,Toshihiko Ezashi,R Michael Roberts
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com